Evidence map›Paper›PMID 38542669›Full record

ReviewNutrients2024

A Comparative Review of Key Isothiocyanates and Their Health Benefits.

Julia B Olayanju, Dragica Bozic, Uma Naidoo, Omowunmi A Sadik

Open access · goldAbstract readReview
In one paragraph

Review in Nutrients, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 33 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
33citing papers in PubMed, 1 pooled it
28.8field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

33 citing papers in PubMed, 1 synthesis or guideline pooled it, 48 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Review
  8. Article
  9. Article
  10. Article
  11. Thiourea-Based HAntioxidants (Basel, Switzerland) · 2026
    Article
  12. Glucosinolate Derivatives: Emerging Anti-Inflammatory Agents.Pharmaceuticals (Basel, Switzerland) · 2026
    Review
  13. Article
  14. Therapeutic Potential ofJournal of inflammation research · 2026
    Review
  15. Organosulfur Compounds: Potential Therapeutics for Parkinson's Disease.CNS & neurological disorders drug targets · 2026
    Review
  16. Review
  17. Article
  18. Review
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 4 institutions in 2 countries.

Julia B OlayanjuDepartment of Biology, Saint Elizabeth University, Morristown, NJ 07960, USA.ORCID 0000-0001-5237-7238
Dragica BozicDepartment of Toxicology, School of Pharmacy, University of Belgrade, 11221 Belgrad, Serbia.ORCID 0000-0002-4746-8407
Uma NaidooHarvard Medical School, Boston, MA 02115, USA.ORCID 0009-0004-6462-4178
Omowunmi A SadikDepartment of Chemistry, New Jersey Institute of Technology, Newark, NJ 07102, USA.
College of Saint Elizabeth · USHarvard University · USNew Jersey Institute of Technology · USUniversity of Belgrade · RS

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Isothiocyanates are biologically active products resulting from the hydrolysis of glucosinolates predominantly present in cruciferous vegetables belonging to the

Indexed as

Anticarcinogenic AgentsBrassicaceaeAnti-Inflammatory AgentsAntioxidantsGlucosinolatesIsothiocyanatesAnticarcinogenic AgentsAnti-Inflammatory AgentsAntioxidantsbenzyl isothiocyanateGlucosinolatesIsothiocyanatesisothiocyanic acidphenylisothiocyanateanticarcinogenicantitumorchemopreventionisothiocyanate

Identifiers

PMID38542669
PMCPMC10974736
OpenAlexW4392563275

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.